These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1388195)

  • 1. Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients.
    Clerici M; Landay AL; Kessler HA; Phair JP; Venzon DJ; Hendrix CW; Lucey DR; Shearer GM
    J Infect Dis; 1992 Oct; 166(4):723-30. PubMed ID: 1388195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
    Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW
    AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta 2-microglobulin levels in asymptomatic HIV-1-infected subjects during long-term zidovudine treatment.
    Mulder JW; Krijnen P; Coutinho RA; Bakker M; Goudsmit J; Lange JM
    Genitourin Med; 1991 Jun; 67(3):188-93. PubMed ID: 1906425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
    Jacobson MA; Abrams DI; Volberding PA; Bacchetti P; Wilber J; Chaisson RE; Crowe S; Howard W; Moss A
    J Infect Dis; 1989 Jun; 159(6):1029-36. PubMed ID: 2566637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
    Ebert S; Gockel K; Horowitz S; Weber P; Vogelman B; Graziano F
    Wis Med J; 1991 Apr; 90(4):161-5. PubMed ID: 1675028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection.
    Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD
    Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI).
    Reddy MM; McKinley GF; Grieco MH
    J Clin Lab Anal; 1991; 5(6):396-8. PubMed ID: 1774603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
    Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of ampligen in human immunodeficiency virus-infected subjects.
    Armstrong JA; McMahon D; Huang XL; Pazin GJ; Gupta P; Rinaldo CR; Schoenfeld DA; Gaccione P; Tripoli CA; Bensasi S
    J Infect Dis; 1992 Oct; 166(4):717-22. PubMed ID: 1527407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults.
    Conge AM; Reynes J; Atoui N; Huguet MF; Ducos J; Bonardet A; Serre A; Vendrell JP
    J Infect Dis; 1994 Dec; 170(6):1376-83. PubMed ID: 7995975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early markers of HIV infection and subclinical disease progression.
    Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN
    Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative viremia and p24 antigenemia in short-term follow-up of the treatment with zidovudine in twenty HIV infected patients].
    Tamalet C; Puel J; Fleury H; Ferchal F; Agut H; Brun-Vezinet F; Botti G; Rouzioux C
    Pathol Biol (Paris); 1993 Apr; 41(4):399-403. PubMed ID: 8233642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with zidovudine for patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex.
    Pinching AJ; Helbert M; Peddle B; Robinson D; Janes K; Gor D; Jeffries DJ; Stoneham C; Mitchell D; Kocsis AE
    J Infect; 1989 Jan; 18 Suppl 1():33-40. PubMed ID: 2521663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals.
    Benson EM; Clarkson J; Law M; Marshall P; Kelleher AD; Smith DE; Patou G; Stewart GJ; Cooper DA; French RA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):105-13. PubMed ID: 10029243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antiviral therapy on the production of anti-human immunodeficiency virus-specific immunoglobulin in infants and children.
    Pollack H; Zhan MX; Moore T; Tao PZ; Krasinski K; Borkowsky W
    J Infect Dis; 1994 Oct; 170(4):1003-6. PubMed ID: 7930694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. AIDS Clinical Trial Research Group 047.
    Liu M; Fahey JL; Aziz N; Cumberland WG; Skowron G; Merigan T
    J Infect Dis; 1994 Nov; 170(5):1165-71. PubMed ID: 7963709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
    J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.